225 related articles for article (PubMed ID: 18360703)
1. Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis.
Pulukuri SM; Rao JS
Int J Oncol; 2008 Apr; 32(4):757-65. PubMed ID: 18360703
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
4. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis.
Cao J; Chiarelli C; Kozarekar P; Adler HL
Thromb Haemost; 2005 Apr; 93(4):770-8. PubMed ID: 15841326
[TBL] [Abstract][Full Text] [Related]
5. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
6. Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer.
Chen F; Wang M; Bai J; Liu Q; Xi Y; Li W; Zheng J
PLoS One; 2014; 9(1):e86917. PubMed ID: 24475196
[TBL] [Abstract][Full Text] [Related]
7. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
[TBL] [Abstract][Full Text] [Related]
9. P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.
Goc A; Al-Azayzih A; Abdalla M; Al-Husein B; Kavuri S; Lee J; Moses K; Somanath PR
J Biol Chem; 2013 Feb; 288(5):3025-35. PubMed ID: 23258534
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
Kaimal R; Aljumaily R; Tressel SL; Pradhan RV; Covic L; Kuliopulos A; Zarwan C; Kim YB; Sharifi S; Agarwal A
Cancer Res; 2013 Apr; 73(8):2457-2467. PubMed ID: 23423981
[TBL] [Abstract][Full Text] [Related]
11. Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis.
Xiaoxia X; Jing S; Dongbin X; Yonggang T; Jingke Z; Yanying Z; Hulai W
Curr Drug Deliv; 2020; 17(2):148-158. PubMed ID: 31939730
[TBL] [Abstract][Full Text] [Related]
12. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells.
Hwang ES; Park KK
Biosci Biotechnol Biochem; 2010; 74(5):961-7. PubMed ID: 20460721
[TBL] [Abstract][Full Text] [Related]
13. Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
Malik MT; Kakar SS
Mol Cancer; 2006 Nov; 5():61. PubMed ID: 17096843
[TBL] [Abstract][Full Text] [Related]
14. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice.
Chetty C; Bhoopathi P; Joseph P; Chittivelu S; Rao JS; Lakka S
Mol Cancer Ther; 2006 Sep; 5(9):2289-99. PubMed ID: 16985063
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
[TBL] [Abstract][Full Text] [Related]
17. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
Huang S; Pettaway CA; Uehara H; Bucana CD; Fidler IJ
Oncogene; 2001 Jul; 20(31):4188-97. PubMed ID: 11464285
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
Choi J; Choi K; Benveniste EN; Rho SB; Hong YS; Lee JH; Kim J; Park K
Cancer Res; 2005 Jul; 65(13):5554-60. PubMed ID: 15994927
[TBL] [Abstract][Full Text] [Related]
19. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Zhang H; Qi M; Li S; Qi T; Mei H; Huang K; Zheng L; Tong Q
Mol Cancer Ther; 2012 Jul; 11(7):1454-66. PubMed ID: 22564723
[TBL] [Abstract][Full Text] [Related]
20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
